Noncompaction cardiomyopathy left ventricular dysfunction
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy left ventricular dysfunction On the Web |
|
FDA on Noncompaction cardiomyopathy left ventricular dysfunction |
|
CDC on Noncompaction cardiomyopathy left ventricular dysfunction |
|
Noncompaction cardiomyopathy left ventricular dysfunction in the news |
|
Blogs on Noncompaction cardiomyopathy left ventricular dysfunction |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy left ventricular dysfunction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The phenotypic expression of NCC is variable, and some, but not all patients have [[left ventricular systolic and or diastolic dysfunction.
Abnormalities in Cardiac Function
- There can be abnormalities in systolic and diastolic function. There can also be hypercontractile dysfunction.
- These patients are at risk of forming mural thrombus in the left ventricle and embolization. As a result, all patients with NCC are treated with prophylactic aspirin.
- There is no communication of the sinusoids with the coronary arteries[1].
References
- ↑ Rigopoulos A, Rizos IK, Aggeli C, et al. Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults. Cardiology. 2002; 98: 25–32.